Volume 3 Issue 4 will be published on Jul 12, 2022.   A Cell Press partner journal
See the unseen. Change the unchanged.
The Innovation ¡ª published by Cell Press in partnership with members of the Youth
Innovation Promotion Association (YIPA),a part of the Chinese Academy of
Sciences¡ªis a new broad-scope, open access journal publishing basic and applied
research that has impact for the benefit of society.
On the cover: Medicine is the practice of the diagnosis, treatment, and prevention of disease. With the advances in medical science, human beings are getting both longer life spans and higher quality of life. From herbs to molecular signatures, humankind is experiencing a transition from traditional medicine to personalized medicine: the right treatment to the right patient at the right time. However, it is not so easy to achieve this goal because the etiology of most diseases and disorders is still unclear. From description to association, numerous researchers are working together to decipher the mechanisms behind disease. To address such challenges, more and more global collaborations are badly needed to include experts from all disciplines: not just doctors, scientists and administration staff, but also engineers, technicians and marketing managers. Not limited to a fish-eye view, we humans should widen our vision and get more deep insights beyond the human community. That is the right way to assure sustainable healthcare for humanity.
Position: Home > Collections > Cancer
> Review
Greenspace and human health: An umbrella review
--Bo-Yi Yang et al.
> Review
Applications and potentials of nanopore sequencing in the (epi)genome and (epi)transcriptome era
--Shangqian Xie et al.
> Review
Nanotechnology-enhanced immunotherapy for metastatic cancer
--Peisen Zhang et al.
> Commentary
Delta.AR: An Augmented Reality-based Visualization Platform for 3D Genome
--Bixia Tang et al.
> Article
ClusterProfiler 4.0: A Universal Enrichment Tool for Interpreting Omics Data
--Tianzhi Wu et al.
> Commentary
On the Ultimate Finishing Line of the Human Genome Project
--Jun Yu et al.
> Review
Acquired Resistance to Third-generation EGFR-TKIs and Emerging Next-generation EGFR Inhibitors
--Xiaojing Du et al.
> Report
Small Molecular NIR-II Fluorophores for Cancer Phototheranostics
--Hanming Dai et al.
> Review
RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
--Chang Gu et al.
> Translational Patent
Innovative Irinotecan-Loaded Nanomicelles Will Enter Phase I Clinical Trial in 2021
--Chan Li et al.
> Review
Overcoming resistance to drugs targeting KRASG12C mutation
--Delong Jiao et al.
> Review
Insights into hepatitis B virus DNA Integration-55 years after virus discovery
--Kaitao Zhao et al.
> Review
Therapy of primary liver cancer
--Mei Feng et al.
> Report
Assessment of spine tumor treatment using implanted 3-dimensional-printed vertebral bodies with robotic stereotactic radiotherapy.
--Hongqing Zhuang et al.
> Review
Current status and future perspective of immunotherapy in gastrointestinal cancers
--Zhihao Lu et al.

 

Host
ISSN 2666-6758
Publishing partner
Journal links
 
Academic co-partner
SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS
INSTITUTE OF MICROBIOLOGY, CAS
XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS
 
Collections

Air Pollution
Astronomy
Cancer
Chemistry & Materials
COVID-19
Environment Changes
Geoscience
Life Science & Medicine
Physics
ScienceX / Interdiscipline

 
Stay connected
  the.innovation.journal
  the.innovation.journal
  The Innovation
  TheInnovation´´ÐÂ
  TheInnovation´´ÐÂ
  The_Innovation
  office@the-innovation.org

Official£º@The_InnovationJ
Astronomy£º@TheInnovationA3
Chemistry£º@InnovationChem
Geoscience£º@TheInnovationG2
Informatics£º@Innovation_inf
Life Science£º@InnovationLS
Management£º@TheInnovationM1
Materials£º@TheInnovationM2
Medicine£º@Theinnovation_m
Physics£º@TheInnovationP1
ScienceX£º@TheInnovSciX

  Copyright © 2019-2022 Youth Innovation All Rights Reserved